Current progress and advances in hepatobiliary cancer:highlights from ESMO congress 2023
成远 1朱小东2
扫码查看
点击上方二维码区域，可以放大扫码查看
作者信息
1. 解放军东部战区总医院全军肿瘤中心,江苏南京 210002
2. 复旦大学附属中山医院肝肿瘤外科,上海 200032
折叠
摘要
2023年欧洲肿瘤内科学会(European Society for Medical Oncology,ESMO)年会于2023年10月20～24日在西班牙马德里召开.本次大会报道多项肝胆恶性肿瘤的临床研究结果,涵盖系统治疗、局部联合系统治疗和围手术期治疗等.这些研究结果将改变临床实践并推动肝胆恶性肿瘤领域的发展.本文重点介绍大会肝细胞癌和胆管恶性肿瘤的相关研究结果,探讨当前的治疗热点、问题和未来发展方向.
Abstract
The 2023 congress of the European Society for Medical Oncology(ESMO)was held in Madrid,Spain,from October 20th to 24th,2023.This conference reported many important studies in the field of hepatobiliary malignancies,including systemic therapy,locoregional therapies in combination with systemic treatment and perioperative therapy.These results will change clinical practice and promote the de-velopment within the field of hepatobiliary malignancies.This article focuses on the research on hepatocellular carcinoma and biliary tract carcinoma at the conference and discusses the hot spots,problems,and future directions.
关键词
肝细胞癌/胆管恶性肿瘤/欧洲肿瘤内科学会/2023
Key words
hepatocellular carcinoma/biliary tract carcinoma/European Society for Medical Oncology/2023
维普
万方数据